Cagrilintide 10mg

The Driada Cagrilintide 10mg Research Vial is manufactured to high purity standards and supplied exclusively for laboratory and scientific research applications.

Each vial contains 10mg of research-grade Cagrilintide in lyophilised (freeze-dried) powder form. Manufactured under strict quality control procedures, every batch is tested to ensure exceptional purity, consistency, and reliability for qualified research professionals.

Product Specifications

Compound: Cagrilintide

Strength: 10mg

Format: Lyophilised Powder

Purity: ≥99%

Appearance: White to off-white lyophilised powder

Storage: Store refrigerated at 2–8°C. Protect from heat, moisture, and direct sunlight.

Research Use Only

Package Contents

1 × Cagrilintide 10mg Research Vial

1 × 1ml Bacteriostatic Water

Important Notice

This product is supplied strictly for laboratory and scientific research purposes only. It is not intended for human or veterinary use, nor for the diagnosis, treatment, cure, or prevention of any disease. Purchasers are solely responsible for ensuring compliance with all applicable laws and regulations within their jurisdiction.

ℹ️ℹ️ℹ️ℹ️

What is Cagrilintide?

Cagrilintide is an investigational long-acting amylin analogue being developed to help treat obesity and support weight management. It mimics amylin, a hormone naturally released by the pancreas after eating that helps regulate appetite and food intake.

Cagrilintide is also being studied in combination with semaglutide for enhanced weight loss.

How It Works

- Reduces appetite and food cravings.

- Increases feelings of fullness after meals.

- Slows stomach emptying, helping you stay satisfied for longer.

- Helps reduce overall calorie intake.

- Works through a different pathway than GLP-1 medications and may provide greater weight loss when used in combination.

Benefits

- Significant weight loss.

- Reduced body fat.

- Improved appetite control.

- Reduced waist circumference.

- May improve metabolic health and obesity-related risk factors.

Bodybuilding & Wellness

- Primarily used during a cutting phase to support fat loss.

- Makes it easier to maintain a calorie deficit through appetite suppression.

- May help preserve lean muscle mass when combined with adequate protein intake and resistance training.

- Not a muscle-building peptide and does not directly increase strength or muscle size.

Side Effects

- Nausea.

- Vomiting.

- Diarrhoea.

- Constipation.

- Stomach discomfort.

- Reduced appetite.

Potential Risks

- Dehydration from severe vomiting or diarrhoea.

- Gallbladder problems.

- Possible pancreatitis (rare).

- Limited long-term safety data while clinical trials continue.

- May increase the risk of gastrointestinal side effects, particularly when combined with GLP-1 receptor agonists.

How It Is Taken

- Administered as a once-weekly subcutaneous injection.

- The dose is gradually increased to improve tolerability and minimise gastrointestinal side effects.

- Often studied in combination with semaglutide for greater weight-loss effects.

Current Status

Cagrilintide is currently undergoing clinical trials for obesity treatment and has not yet received widespread regulatory approval as a standalone medication in many countries. Research to evaluate its long-term safety and effectiveness is ongoing.

Summary

Cagrilintide is a promising investigational peptide for weight management that works by mimicking the natural hormone amylin to reduce appetite and increase fullness. Clinical studies have shown encouraging weight-loss results, particularly when combined with GLP-1 therapies such as semaglutide. It is intended for fat loss and metabolic health, not muscle growth, and should only be used under appropriate medical supervision.

#cag #ca #10mg #